Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to $3.8 million.

  • Ptc Therapeutics' Treasury Shares rose 535.2% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 535.2%. This contributed to the annual value of $3.5 million for FY2024, which is 2307.2% up from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Treasury Shares is $3.8 million, which was up 535.2% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Treasury Shares ranged from a high of $3.9 million in Q1 2025 and a low of $1.5 million during Q1 2021
  • Moreover, its 5-year median value for Treasury Shares was $3.4 million (2023), whereas its average is $2.9 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Treasury Shares skyrocketed by 6826.69% in 2022, and later plummeted by 38.97% in 2024.
  • Ptc Therapeutics' Treasury Shares (Quarter) stood at $1.5 million in 2021, then soared by 65.57% to $2.5 million in 2022, then grew by 13.91% to $2.9 million in 2023, then rose by 23.07% to $3.5 million in 2024, then increased by 7.41% to $3.8 million in 2025.
  • Its Treasury Shares was $3.8 million in Q3 2025, compared to $3.8 million in Q2 2025 and $3.9 million in Q1 2025.